Clinical trial
Assessment of Residual Allergenicity of Ragweed Pollen Allergoid With…
NCT00116285 · Allergy Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00116285 |
|---|---|
| Title | Assessment of Residual Allergenicity of Ragweed Pollen Allergoid With Monophosphoryl Lipid A (MPL) Using Skin Prick Testing |
| Official title | A Single-Blind Phase I Study to Assess the Residual Allergenicity of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL Using Skin Prick Testing |
| Lead sponsor | Allergy Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Type I Hypersensitivity |
| Intervention type | Biological |
| Interventions | Ragweed MATA MPL |
| Enrollment | 12 |
| Start date | Jun 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | Jun 29, 2005 |
| Last update posted | Jun 17, 2010 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: